Type 1 Diabetes
Top in endocrinology: Add-on PPI therapy, tirzepatide for type 2 diabetes
Recent data showed that add-on proton pump inhibitor therapy was associated with a significant decrease in HbA1c and fasting blood glucose. However, it did not reduce the risk for incident diabetes.
Daily oral insulin improves metabolic markers in children at high risk for type 1 diabetes
Daily oral insulin therapy may improve glucose and C-peptide measurements for a subset of children at high risk for type 1 diabetes, according to new TrialNet data presented at the American Diabetes Association Scientific Sessions.
Statement outlines strategies for recovery after exercise in type 1 diabetes
Adults with type 1 diabetes should take several key steps to optimize recovery after exercise, such as adjusting insulin dosing and protein and carbohydrate intake, and carefully monitoring blood glucose, according to a consensus statement.
DKA rates rise for youths with type 1 diabetes in countries with higher COVID-19 mortality
Diabetic ketoacidosis events increased among youths with type 1 diabetes in the U.S. and other countries hit hard by the first wave of the COVID-19 pandemic, according to a study published in Diabetes Technology and Therapeutics.
Machine learning models outperform glucose management indicator in estimating HbA1c
Machine learning models using continuous glucose monitor and demographic data were more accurate at estimating HbA1c for people with type 1 diabetes compared with the glucose management indicator, according to study data.
ADA updates standards of care to reflect new teplizumab, HF data
The American Diabetes Association issued updates to the 2021 Standards of Medical Care in Diabetes to reflect new data on the immunotherapy teplizumab for type 1 diabetes and heart failure benefits seen with SGLT2 inhibitors.
Switch from intermittent to real-time CGM improves time in range, quality of life measures
Adults with type 1 diabetes who switched from intermittently scanned to real-time continuous glucose monitoring saw improved time in range and quality of life measures at 6 months compared with those who did not make the change, data show.
Dasiglucagon studies show safety for children, adults experiencing severe hypoglycemia
A next-generation glucagon analog provided rapid and effective treatment of severe hypoglycemia for children and adults with type 1 diabetes, without the need to reconstitute lyophilized powder used in traditional glucagon rescue kits.
Hypoglycemic, hyperglycemic events increase dementia risk in adults with type 1 diabetes
Severe hypoglycemic and hyperglycemic events correlated with increased risk for dementia among older adults with type 1 diabetes, according to a longitudinal cohort study of more than 2,800 patients published in Neurology.
Women with type 1 diabetes reach CGM targets later in pregnancy
Pregnant women with type 1 diabetes using a continuous glucose monitor improved their time in range from their first trimester to 34 weeks of pregnancy, according to study data.